| Trial ID: | L0757 |
| Source ID: | NCT03528707
|
| Associated Drug: |
Probiotic
|
| Title: |
Effect of Probiotic Co-administration With Omega-3 Fatty Acids on NAFLD: Randomized Clinical Studies
|
| Acronym: |
--
|
| Status: |
Not recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Type2 Diabetes;NAFLD;Probiotic;Omega-3 Fatty Acids
|
| Interventions: |
Dietary Supplement: Symbiter-Omega;Dietary Supplement: Placebo
|
| Outcome Measures: |
fatty liver index (FLI);liver stiffness (LS)ALT;AST;?-GT;Total Cholesterol (TC);Tryglicerides (TG);LDL-Cholesterol (LDL-C);VLDL-Cholesterol (VLDL-C);HDL-Cholesterol (HDL-C);cytokines levels
|
| Sponsor/Collaborators: |
Bogomolets National Medical University
|
| Gender: |
All
|
| Age: |
18 Years75 Years
|
| Phases: |
Not applicable
|
| Enrollment: |
48
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Triple (Participant, Investigator, Outcomes Assessor).
|
| Start Date: |
01/05/2018
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
12 December 2020
|
| Locations: |
--
|
| URL: |
https://clinicaltrials.gov/show/NCT03528707
|
